Plain-English translation of NCT05924477 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Glaucoma is a condition where increased eye pressure damages the optic nerve and can lead to vision loss. This trial is testing a glaucoma drainage device—a small tube that helps fluid drain from your eye to lower pressure. The study compares two different locations where surgeons can place this tube inside your eye to see which location is safer and more effective for your vision long-term.
Doctors need to know which surgical placement of the drainage tube causes the least damage to the delicate cells in the front of the eye (the corneal endothelium) while still effectively lowering eye pressure. This information will help surgeons choose the best approach for each patient.
You likely qualify if…
You likely don't qualify if…
You will have glaucoma drainage surgery where the surgeon randomly places your drainage tube in one of two locations inside your eye. Some participants may have this surgery combined with cataract surgery if needed. After surgery, you will return for follow-up visits over 24 months where doctors will check your eye pressure, measure the health of your corneal cells, and monitor your vision and recovery.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States